Compass Pathways Stock (NASDAQ: CMPS) stock price, news, charts, stock research, profile.
You can purchase shares of Compass Pathways (NASDAQ:CMPS) through any online brokerage.
Other companies in Compass Pathways’s space includes: 4D Molecular Therapeutics (NASDAQ:FDMT), Voyager Therapeutics (NASDAQ:VYGR), Larimar Therapeutics (NASDAQ:LRMR), Eledon Pharma (NASDAQ:ELDN) and aTyr Pharma (NASDAQ:ATYR).
Compass Pathways has a consensus price target of $29.60.
The stock price for Compass Pathways (NASDAQ: CMPS) is $4.0388 last updated December 24, 2024 at 3:47 PM EST.
There are no upcoming dividends for Compass Pathways.
Compass Pathways’s Q4 earnings are confirmed for Thursday, February 27, 2025.
There is no upcoming split for Compass Pathways.
Compass Pathways is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.